These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34726095)

  • 1. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.
    Hervera B; Seo G; Bartholomew TS; Chueng TA; Suarez E; Forrest DW; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Serota DP
    Addict Sci Clin Pract; 2023 Feb; 18(1):8. PubMed ID: 36747268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical Control.
    Serota DP; Rosenbloom L; Hervera B; Seo G; Feaster DJ; Metsch LR; Suarez E; Chueng TA; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Bartholomew TS
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac688. PubMed ID: 36632415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study Protocol to Increase Engagement in Evidence Based Hospital and Community Based Care Using a Serious Injection Related Infections (SIRI) Checklist and Enhanced Peer for Hospitalized PWID (ShaPe).
    Baldwin M; Jeziorski M; Parman M; Gagnon K; Nichols MA; Bradford D; Crockett K; Eaton E
    Res Sq; 2023 Jun; ():. PubMed ID: 37333109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts.
    Kimmel SD; Walley AY; White LF; Yan S; Grella C; Majeski A; Stein MD; Bettano A; Bernson D; Drainoni ML; Samet JH; Larochelle MR
    JAMA Netw Open; 2024 Jul; 7(7):e2421740. PubMed ID: 39046742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.
    Thakarar K; Rokas KE; Lucas FL; Powers S; Andrews E; DeMatteo C; Mooney D; Sorg MH; Valenti A; Cohen M
    PLoS One; 2019; 14(11):e0225460. PubMed ID: 31770395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: A matched cohort study.
    Robertson NM; Mangino AA; South AM; Fanucchi LC
    J Subst Use Addict Treat; 2024 May; 160():209298. PubMed ID: 38262559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients With Serious Injection Drug Use-Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care.
    Lewis S; Liang SY; Schwarz ES; Liss DB; Winograd RP; Nolan NS; Durkin MJ; Marks LR
    Open Forum Infect Dis; 2022 Feb; 9(2):ofab633. PubMed ID: 35106316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014-18.
    Jo Y; Nosal R; Vittori A; Cordova L; Vandever C; Alvarez C; Bartholomew TS; Tookes HE
    Addiction; 2021 Aug; 116(8):2127-2134. PubMed ID: 33394516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges Remain.
    Eaton EF; Lee RA; Westfall AO; Mathews RE; McCleskey B; Paddock CS; Lane PS; Cropsey KL
    J Infect Dis; 2020 Sep; 222(Suppl 5):S499-S505. PubMed ID: 32877555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018.
    Capizzi J; Leahy J; Wheelock H; Garcia J; Strnad L; Sikka M; Englander H; Thomas A; Korthuis PT; Menza TW
    PLoS One; 2020; 15(11):e0242165. PubMed ID: 33166363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not Just Endocarditis: Hospitalizations for Selected Invasive Infections Among Persons With Opioid and Stimulant Use Diagnoses-North Carolina, 2010-2018.
    Sredl M; Fleischauer AT; Moore Z; Rosen DL; Schranz AJ
    J Infect Dis; 2020 Sep; 222(Suppl 5):S458-S464. PubMed ID: 32877536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis.
    Kimmel SD; Walley AY; Li Y; Linas BP; Lodi S; Bernson D; Weiss RD; Samet JH; Larochelle MR
    JAMA Netw Open; 2020 Oct; 3(10):e2016228. PubMed ID: 33052402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016-2017.
    Serota DP; Bartholomew TS; Tookes HE
    Clin Infect Dis; 2021 Oct; 73(7):e1649-e1657. PubMed ID: 32886747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
    Fanucchi LC; Murphy SM; Surratt H; Kapadia SN; Walsh SL; Grubbs JA; Thornton AC; Nuzzo P; Lofwall MR
    Ther Adv Infect Dis; 2022; 9():20499361221108005. PubMed ID: 35847566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Linkage for Patients With Injection-Drug-Use-Related Endocarditis and Osteomyelitis to Medications for Opioid Use Disorder Through a Telephone Intervention.
    Harris C; Roy PJ; Mitchell AM; Anderson MW
    J Addict Nurs; 2024 Jul-Sep 01; 35(3):132-136. PubMed ID: 39356584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs.
    Fanucchi LC; Lofwall MR; Nuzzo PA; Walsh SL
    J Subst Abuse Treat; 2018 Sep; 92():64-69. PubMed ID: 30032946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-center Observational Study.
    Hrycko A; Mateu-Gelabert P; Ciervo C; Linn-Walton R; Eckhardt B
    J Addict Med; 2023 May-Jun 01; 17(3):e202-e205. PubMed ID: 37267185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina.
    Figgatt MC; Salazar ZR; Vincent L; Carden-Glenn D; Link K; Kestner L; Yates T; Schranz A; Joniak-Grant E; Dasgupta N
    Harm Reduct J; 2021 Jul; 18(1):80. PubMed ID: 34330297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida.
    Tookes H; Diaz C; Li H; Khalid R; Doblecki-Lewis S
    PLoS One; 2015; 10(6):e0129360. PubMed ID: 26075888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.